Kursprognose für Legend Biotech Corp (LEGN)LEGNLegend Biotech Corp

Alphio's LEGN stock price prediction model matches the current Legend Biotech Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.51 (+0.15%). The 1-week path is $18.78 (+1.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Legend Biotech Corp (LEGN) is currently trading at $18.48, which is significantly below its 200-day simple moving average of $22.236, suggesting it may not be a strong buy at this moment. The RSI is at 45.875, indicating it is neither overbought nor oversold. While the company reported a profit of $33.2 million in Q2 2026, a notable improvement from a loss of $125.4 million in the same quarter last year, the overall trend shows a year-to-date decline of 14.09% and a one-year decline of 43.85%. The recent FDA IND clearance for LB2501 is a positive catalyst, but the stock's performance and analyst downgrades suggest caution. The main risk is the significant decline in net income, which was -$54.3 million in Q1 2026, highlighting ongoing financial challenges.

Legend Biotech Corp (LEGN) last closed at $18.48, losing -6.67%. These facts feed the 1-day and 1-week LEGN price prediction above.